BEL 20 Index Falls 0.88% on Weakness in Healthcare and Basic Materials

Belgian stocks finished Monday's trading session in negative territory, with the benchmark BEL 20 index declining by 0.88%. The downturn was driven by broad-based selling pressure, particularly in the Consumer Goods, Basic Materials, and Healthcare sectors.

Market Performance

The negative sentiment in Brussels was reflected in the market's breadth. According to data from the Brussels Stock Exchange, falling stocks significantly outnumbered advancing ones by a margin of 63 to 27, while 12 issues ended the day unchanged. This indicates widespread selling pressure rather than a decline isolated to a few large-cap names.

Stock-Specific Movers

Several prominent companies led the index lower. The worst performers of the session included:

Ad

• Argen-X (EBR:ARGX), which fell 2.71%.
• Aperam SA (AS:APAM), declining 2.63%.
• Azelis Corporate Services NV (EBR:AZE), which was down 2.52%.

In contrast, a few stocks managed to post gains against the market trend. Semiconductor company Melexis NV (EBR:MLXS) was the top performer on the BEL 20, rising 3.04%. Other notable gainers were investment firm Sofina (EBR:SOF), which added 1.43%, and grid operator Elia (EBR:ELI), up 1.09%.

Broader Market Context

In the wider commodities market, crude oil prices advanced, while Gold Futures for December delivery edged lower. In foreign exchange, major currency pairs involving the euro, such as EUR/USD and EUR/GBP, remained relatively stable with minimal changes reported at the close of the European session.